Sunday, July 31, 2011

Big Pharma looks to capitalize on success of vitamin D by turning it into a 'drug' for kidney disease

It can never be stressed enough: only an FDA-approved drug can cure or treat disease. At least, that's what the law says. It took them a while to figure out, but now they will patent vitamin D for distribution for profit at pharmaceutical prices.

As Codex Alimentarius is incrementally implemented, more and more of your vitamins and supplements will be declared drugs, and you will need a prescription for them. And even then, except for fluoride of course, most of those vitamins and supplements will be in doses so inadequate they're not even worth taking. This leaves you with but one choice: cultivate your own vitamins, naturally. Learn which fruits and vegetables give you the vitamins your body needs, and grow them organically. For Vitamin D, don't fear the sun. No matter how bad they tell you it is for you.

    Natural News -

    With an incredible success rate for vitamin D in treating a myriad of health conditions, it is no wonder that some drug companies are looking for new ways to capitalize on this natural, inexpensive nutrient.

    Biopharmaceutical giant Rockwell Medical recently announced that it has acquired a US Food and Drug Administration (FDA) Abbreviated New Drug Application (ANDA) for a generic, injectable form of vitamin D called Calcitriol, that it openly refers to as a "drug."

    Marketed under several brand names including Rocaltrol (Roche), Calcijex (Abbott), and Decostriol (Mibe, Jesalis), Calcitriol is really nothing more than vitamin D3, or 1,25-dihydroxycholecalciferol, that has been placed in a syringe with sterile fluids and other additives. And yet Rockwell Medical, as well as various medical information sources, refer to Calicitriol as a "drug," which is why Rockwell Medical obtained an ANDA in the first place.

Read it all.